Quiz

Real-World Effectiveness of Risankizumab

11/24/2021

Newer IL-23 Inhibitor Demonstrates Improvement in Nail, Scalp, and Palmoplantar Psoriasis

Several recent studies have demonstrated improvement in localized nail, scalp, and palmoplantar psoriasis after treatment with risankizumab. The studies showed results in both real-world and clinical trial settings.

KOL Insights

Videos

Dr Blauvelt on Improvements in Safety in Biologic Therapies

08/13/2020

In the video below, Andrew Blauvelt, MD, MBA, discusses how the thought on safety with biologic use has changed over the years.

In the video below, Andrew...

08/13/2020

The Dermatologist

Quiz

Trivia: Treating Localized Psoriasis

10/08/2021

Risankizumab demonstrated significant improvement vs placebo and ustekinumab in which areas of localized psoriasis?

Risankizumab demonstrated...

10/08/2021

The Dermatologist

Videos

Dr Blauvelt on the Comparative Durability and Safety of Biologics

07/20/2020

Andrew Blauvelt, MD, MBA, details the differences in maintenance of response and safety of various biologic therapies for the treatment of plaque psoriasis.

Andrew Blauvelt, MD, MBA,...

07/20/2020

The Dermatologist

Quiz

Trivia: Hair Loss and Psoriasis

10/26/2021

True or false: If left untreated, scalp psoriasis can cause permanent hair loss.

True or false: If left...

10/26/2021

The Dermatologist

Real-World Effectiveness of Risankizumab

KOL Insights

Specialties

Events

Year Round Education

HMP Global Products